OMKAR SPL CHEM LTD

28.55 +0.15 (+0.53%) Buy

OMKARCHEM continues it's uptrend, although on a weaker note

13 min read

OMKARCHEM managed to outperform the broader market today. On a longer term basis, investors in OMKAR SPL CHEM LTD made -0.06% per day. Tuesday's performance of +0.53% was a outperformance compared to it's daily average.

[Themes containing OMKARCHEM]

Buy-and-Hold investors in OMKARCHEM experienced a maximum drawdown of -25.98% over the last three months. It surged by +194.33% during this strong bullish trending period. There were both Long and Short signals during this period, while the long signals were significantly more profitable than the short signals. The net profit from Long signals was +146.12%.

Trend

OMKARCHEM has been outperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 12 Jan, 2016 to 28 Aug, 2018. Over the last 3 years and 1 month, OMKARCHEM underperformed the NIFTY-50 index on 52% days.

OMKARCHEM was profitable on 71% days in the last three months. During this time, it delivered on average +1.79% per day. It delivered it's worst daily return of -5.0%, during this period, on Friday, 28 Dec, 2018. The longest stort-term trend during this period was 19 profitable days, which started on 27 Nov, 2018 and went on till 21 Dec, 2018. This bullish trend returned +88.63% to investors.

The last 12 months saw OMKARCHEM's investors making profits in 4 months and incurring losses in 8 months. OMKARCHEM was less consistent in delivering monthly returs than NIFTY-50 index. OMKARCHEM significantly outperformed NIFTY-50 index in Dec 2018, when it returned +54.65% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. OMKARCHEM had a longer winning streak of losing months than NIFTY-50 index. It went down in 5 straight months (from Jun 2018 to Oct 2018) during which period it delivered -60.25%.

"In the absence of the gold standard, there is no way to protect savings from confiscation through inflation. There is no safe store of value.

OMKARCHEM is currently seeing overall increase in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in OMKARCHEM's volatility from 23 Oct, 2018 to 1 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that OMKARCHEM has positive skewness in it's return distribution. This indicates that investors can expect OMKARCHEM to make attempts to recover from drawdowns quickly. Which makes OMKARCHEM a good candidate for momentum based trading on short-term bullish trends or counter-trends.

NIFTY-50 index has more chance of extreme outcomes than OMKARCHEM. Therefore, NIFTY-50 must receive a lower allocation than OMKARCHEM in your portfolio. OMKARCHEM usually has shorter drawdown period than the NIFTY-50 index.

On a general note (since you are interested in OMKARCHEM), three instruments that are extremely volatile are HATSUN, ~HOMEAPPLIANCES and IGARASHI. They must all be evaluated prudently and investors are better off avoiding them at the moment.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter